[Ala12]MCD peptide: A lead peptide to inhibitors of immunoglobulin E binding to mast cell receptors

A. Buku, B. A. Condie, Joseph Price, M. Mezei

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

An effort was made to discover mast cell degranulating (MCD) peptide analogs that bind with high affinity to mast cell receptors without triggering secretion of histamine or other mediators of the allergic reaction initiated by immunoglobulin E (IgE) after mast cell activation. Such compounds could serve as inhibitors of IgE binding to mast cell receptors. An alanine scan of MCD peptide reported previously showed that the analog [Ala12]MCD was 120-fold less potent in histamine-releasing activity and fivefold more potent in binding affinity to mast cell receptors than the parent MCD peptide. Because this analog showed marginal intrinsic activity and good binding affinity it was subsequently tested in the present study as an IgE inhibitor. In contrast to MCD peptide, [Ala12]MCD showed a 50% inhibition of IgE binding to the FcεRIα mast cell receptor by using rat basophilic leukemia (RBL-2H3) mast cells and fluorescence polarization. Furthermore, in a β- hexosaminidase secretory assay, the peptide also showed a 50% inhibition of the secretion of this enzyme caused by IgE. An attempt was made to relate structural changes and biologic differences between the [Ala12]MCD analog and the parent MCD peptide. The present results show that [Ala12]MCD may provide a base for designing agents to prevent IgE/FcεRIα interactions and, consequently, allergic conditions. Copyright Blackwell Munksgaard, 2005.

Original languageEnglish
Pages (from-to)132-137
Number of pages6
JournalJournal of Peptide Research
Volume66
Issue number3
DOIs
StatePublished - 1 Sep 2005

Fingerprint

Mast Cells
Immunoglobulin E
Peptides
Histamine
Hexosaminidases
Alanine
mast cell degranulating peptide
peptide A
Rats
Assays
Fluorescence
Chemical activation
Fluorescence Polarization
Polarization
Enzymes
Hypersensitivity
Leukemia

Keywords

  • FcεRIα receptor
  • Fluorescence polarization
  • Immunoglobulin E
  • Mast cell degranulating peptide
  • Rat basophilic leukemia cells
  • β-hexosaminidase

Cite this

@article{bf3589893d124ece8a68cd48121e866e,
title = "[Ala12]MCD peptide: A lead peptide to inhibitors of immunoglobulin E binding to mast cell receptors",
abstract = "An effort was made to discover mast cell degranulating (MCD) peptide analogs that bind with high affinity to mast cell receptors without triggering secretion of histamine or other mediators of the allergic reaction initiated by immunoglobulin E (IgE) after mast cell activation. Such compounds could serve as inhibitors of IgE binding to mast cell receptors. An alanine scan of MCD peptide reported previously showed that the analog [Ala12]MCD was 120-fold less potent in histamine-releasing activity and fivefold more potent in binding affinity to mast cell receptors than the parent MCD peptide. Because this analog showed marginal intrinsic activity and good binding affinity it was subsequently tested in the present study as an IgE inhibitor. In contrast to MCD peptide, [Ala12]MCD showed a 50{\%} inhibition of IgE binding to the FcεRIα mast cell receptor by using rat basophilic leukemia (RBL-2H3) mast cells and fluorescence polarization. Furthermore, in a β- hexosaminidase secretory assay, the peptide also showed a 50{\%} inhibition of the secretion of this enzyme caused by IgE. An attempt was made to relate structural changes and biologic differences between the [Ala12]MCD analog and the parent MCD peptide. The present results show that [Ala12]MCD may provide a base for designing agents to prevent IgE/FcεRIα interactions and, consequently, allergic conditions. Copyright Blackwell Munksgaard, 2005.",
keywords = "FcεRIα receptor, Fluorescence polarization, Immunoglobulin E, Mast cell degranulating peptide, Rat basophilic leukemia cells, β-hexosaminidase",
author = "A. Buku and Condie, {B. A.} and Joseph Price and M. Mezei",
year = "2005",
month = "9",
day = "1",
doi = "10.1111/j.1399-3011.2005.00281.x",
language = "English",
volume = "66",
pages = "132--137",
journal = "Journal of Peptide Research",
issn = "1397-002X",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "3",

}

[Ala12]MCD peptide : A lead peptide to inhibitors of immunoglobulin E binding to mast cell receptors. / Buku, A.; Condie, B. A.; Price, Joseph; Mezei, M.

In: Journal of Peptide Research, Vol. 66, No. 3, 01.09.2005, p. 132-137.

Research output: Contribution to journalArticle

TY - JOUR

T1 - [Ala12]MCD peptide

T2 - A lead peptide to inhibitors of immunoglobulin E binding to mast cell receptors

AU - Buku, A.

AU - Condie, B. A.

AU - Price, Joseph

AU - Mezei, M.

PY - 2005/9/1

Y1 - 2005/9/1

N2 - An effort was made to discover mast cell degranulating (MCD) peptide analogs that bind with high affinity to mast cell receptors without triggering secretion of histamine or other mediators of the allergic reaction initiated by immunoglobulin E (IgE) after mast cell activation. Such compounds could serve as inhibitors of IgE binding to mast cell receptors. An alanine scan of MCD peptide reported previously showed that the analog [Ala12]MCD was 120-fold less potent in histamine-releasing activity and fivefold more potent in binding affinity to mast cell receptors than the parent MCD peptide. Because this analog showed marginal intrinsic activity and good binding affinity it was subsequently tested in the present study as an IgE inhibitor. In contrast to MCD peptide, [Ala12]MCD showed a 50% inhibition of IgE binding to the FcεRIα mast cell receptor by using rat basophilic leukemia (RBL-2H3) mast cells and fluorescence polarization. Furthermore, in a β- hexosaminidase secretory assay, the peptide also showed a 50% inhibition of the secretion of this enzyme caused by IgE. An attempt was made to relate structural changes and biologic differences between the [Ala12]MCD analog and the parent MCD peptide. The present results show that [Ala12]MCD may provide a base for designing agents to prevent IgE/FcεRIα interactions and, consequently, allergic conditions. Copyright Blackwell Munksgaard, 2005.

AB - An effort was made to discover mast cell degranulating (MCD) peptide analogs that bind with high affinity to mast cell receptors without triggering secretion of histamine or other mediators of the allergic reaction initiated by immunoglobulin E (IgE) after mast cell activation. Such compounds could serve as inhibitors of IgE binding to mast cell receptors. An alanine scan of MCD peptide reported previously showed that the analog [Ala12]MCD was 120-fold less potent in histamine-releasing activity and fivefold more potent in binding affinity to mast cell receptors than the parent MCD peptide. Because this analog showed marginal intrinsic activity and good binding affinity it was subsequently tested in the present study as an IgE inhibitor. In contrast to MCD peptide, [Ala12]MCD showed a 50% inhibition of IgE binding to the FcεRIα mast cell receptor by using rat basophilic leukemia (RBL-2H3) mast cells and fluorescence polarization. Furthermore, in a β- hexosaminidase secretory assay, the peptide also showed a 50% inhibition of the secretion of this enzyme caused by IgE. An attempt was made to relate structural changes and biologic differences between the [Ala12]MCD analog and the parent MCD peptide. The present results show that [Ala12]MCD may provide a base for designing agents to prevent IgE/FcεRIα interactions and, consequently, allergic conditions. Copyright Blackwell Munksgaard, 2005.

KW - FcεRIα receptor

KW - Fluorescence polarization

KW - Immunoglobulin E

KW - Mast cell degranulating peptide

KW - Rat basophilic leukemia cells

KW - β-hexosaminidase

UR - http://www.scopus.com/inward/record.url?scp=23844506520&partnerID=8YFLogxK

U2 - 10.1111/j.1399-3011.2005.00281.x

DO - 10.1111/j.1399-3011.2005.00281.x

M3 - Article

C2 - 16083440

AN - SCOPUS:23844506520

VL - 66

SP - 132

EP - 137

JO - Journal of Peptide Research

JF - Journal of Peptide Research

SN - 1397-002X

IS - 3

ER -